UBP1 Antibody (YA8218)

UBP1 (Upstream-Binding Protein 1) is a sequence-specific DNA-binding transcription factor belonging to the CP2/GRH family and functions as a promoter context-dependent transcriptional regulator^[1][2]. UBP1 regulates gene expression in erythroid and placental systems, including activation of the α-globin promoter through cooperation with TFCP2 and modulation of CYP11A1/P450scc transcription involved in steroidogenic pathways^[1][2][3]. Mechanistically, UBP1 participates in transcriptional control networks that influence cellular differentiation and tissue-specific gene expression, linking DNA-binding activity to developmental and endocrine regulatory processes^[1][3]. In disease-related contexts, UBP1 has been studied extensively in HIV-1 transcriptional regulation, where it binds sequences near the viral initiation region and represses transcription by interfering with TFIID recruitment to the TATA-box^[2][4][5]. This regulatory activity distinguishes UBP1 from related CP2 family members because its documented roles include both transcriptional activation and transcriptional repression depending on promoter architecture and cellular context^[1][2][3]. Compared with related isoforms and dimerization partners such as TFCP2L1, UBP1 contributes to placental steroidogenic gene regulation while remaining integrated within broader TFCP2-family transcriptional complexes^[3]. No widely established agonists or selective inhibitors of UBP1 have been reported in the cited literature; therefore, current research applications primarily utilize UBP1 as a molecular regulator for studies of transcriptional control, placental biology, erythroid gene expression, and host-virus interactions^[1][2][3][4].